Archrock, Inc.
Archrock, Inc. (AROC) Financial Performance & Income Statement Overview
Access detailed quarterly and annual financial reports for Archrock, Inc. (AROC), covering cash flow, earnings, and balance sheets.
Archrock, Inc. (AROC) Income Statement & Financial Overview
Analyze Archrock, Inc.’s AROC earnings with segmented quarterly and yearly financial statement figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $347.16M | $326.42M | $292.16M | $270.53M |
| Cost of Revenue | $182.68M | $175.25M | $162.58M | $158.29M |
| Gross Profit | $164.49M | $151.17M | $129.58M | $112.24M |
| Gross Profit Ratio | $0.47 | $0.46 | $0.44 | $0.41 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $37.21M | $42.23M | $34.06M | $31.16M |
| Operating Expenses | $37.21M | $42.23M | $129.58M | $31.16M |
| Total Costs & Expenses | $219.88M | $217.48M | $292.16M | $189.45M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $37.74M | $38.24M | $30.18M | $27.86M |
| Depreciation & Amortization | $58.82M | $58.13M | $114.20M | $44.73M |
| EBITDA | $188.55M | $174.73M | $132.47M | $120.07M |
| EBITDA Ratio | $0.54 | $0.54 | $0.45 | $0.44 |
| Operating Income | $127.28M | $108.94M | $95.52M | $81.07M |
| Operating Income Ratio | $0.37 | $0.33 | $0.33 | $0.30 |
| Other Income/Expenses (Net) | -$35.29M | -$30.57M | -$42.57M | -$33.59M |
| Income Before Tax | $91.99M | $78.36M | $52.95M | $47.48M |
| Income Before Tax Ratio | $0.26 | $0.24 | $0.18 | $0.18 |
| Income Tax Expense | $21.14M | $18.60M | $15.44M | $13.05M |
| Net Income | $70.85M | $59.76M | $37.52M | $34.42M |
| Net Income Ratio | $0.20 | $0.18 | $0.13 | $0.13 |
| EPS | $0.40 | -$0.68 | $0.22 | $0.22 |
| Diluted EPS | $0.40 | -$0.68 | $0.22 | $0.22 |
| Weighted Avg Shares Outstanding | $174.01M | $173.45M | $165.85M | $154.50M |
| Weighted Avg Shares Outstanding (Diluted) | $174.37M | $173.85M | $166.17M | $154.78M |
Over the past four quarters, Archrock, Inc. demonstrated steady revenue growth, increasing from $270.53M in Q2 2024 to $347.16M in Q1 2025. Operating income reached $127.28M in Q1 2025, maintaining a consistent 37% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $188.55M, reflecting operational efficiency. Net income rose to $70.85M, with EPS at $0.40. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan